Grupo Farmasierra safeguards its future by making solid, on-going investments in research, development and innovation through a range of different activities.

Its work teams are highly skilled in the knowledge and implementation of Good Manufacturing Practices (GMPs) and in designing and implementing development projects in compliance with the ICH Q8 and Q9 standards.

The firm has analysis and galenic development laboratories equipped with state-of-the-art systems and equipment, which allows for efficient work and the completion of projects within established deadlines.

Grupo Farmasierra's research, development and innovation activities always comply with the requirement that the products or technologies developed be technically and economically feasible on an industrial scale.

The pharmaceutical plant has a duly authorised area for preparing medicinal research.

Activity Area: Research on New Products
Grupo Farmasierra collaborates with other companies in researching new active principles and new therapeutic indications for known active principles.

It studies various vehiculisation systems for new molecules to achieve their proper administration and the optimisation of bioavailability.

The research lines focus on different pathologies and the field of prevention.

Activity Area: Development of Dosage Forms and New Technologies
The company's wide-ranging experience in the galenic development of new dosage forms for various purposes, such as improved sensory characteristics, enhanced bioavailability and the extension of lines, endorses Grupo Farmasierra's capacity for innovation.

Its collaboration with other companies in the technology field is a constant and it actively participates in generating new dosage technologies and concepts that allow it to overcome the problems inherent in conventional dosage forms.

Prominent among the products already developed are various solid forms: tablets, coated tablets, chewable tablets, effervescent tablets, directly compressed gum, effervescent powder, powder for suspensions, extemporaneous solutions, suspension products hard to solubilise in aqueous medium and so on. Also noteworthy are liquid forms such as syrups and suspensions, as well as solutions with active principles impregnated on synthetic supports. Among the semisolid forms developed are all sorts of topical gels, creams and ointments.

Activity Area: Preparation of Medicines for Clinical Trials (Investigational Medicinal Products)
The Grupo Farmasierra firm Farmasierra Manufacturing is certified as a Medicines Manufacturer and Researcher by the Spanish Agency of Pharmaceuticals and Medical Devices and has duly qualified facilities and staff trained for this activity.

The medicinal products research preparation service as well as industrial-scale manufacturing service is offered internationally. Our clients include companies of renowned prestige.

Grupo Farmasierra's high interest in achieving optimum levels of service ensures that it provides its services properly in a timely manner.

Activity Area: Industrial Scaling
Registering medicines requires scale jumping in the preparation of validation batches or, in the event, biobatches during one or more stages that span the laboratory to the industrial level.

Grupo Farmasierra has the facilities, equipment and staff needed to perform such operations. Furthermore, it designs and conducts the stability studies needed in accordance with the ICH conditions required for registering medicinal products.

The Pharmaceutical Engineering and Quality Departments provide the support and service needed for the qualification of equipment, validation of processes, implementation of analytical methods and industrial scaling.

Activity Area: Technology Transfer
Grupo Farmasierra has staff with the education and skills required to perform the technology transfer needed and to implement it in the Farmasierra Manufacturing facilities.



Research and development of new products

The Farmasierra Manufacturing, S. L. firm, which belongs to Grupo Farmasierra, has received grants for its R&D&I projects from the Community of Madrid's Ministry of the Economy and Technological Innovation and the European Regional Development Fund.
Si no recuerda sus datos de acceso escriba la dirección de correo electrónico con la que se registró en nuestra web y se los enviaremos por email.
CORREO ELECTRÓNICO
FIRST NAME
SURNAME
E-MAIL
PASSWORD
LICENCE N°
SPECIALITY
PHYSICIAN PHARMACIST
I wish to receive the newsletter with news about Farmasierra
I accept the legal conditions
If you wish to receive Grupo Farmasierra’s newsletter with the latest news about our company’s products and activities and the pharmaceutical sector, please indicate your e-mail address.
E-MAIL
If you wish to cancel your subscription to the Farmasierra Group Newsletter, please fill in the e-mail address where you receive it.
E-MAIL ADDRESS

• Diríjase hacia el nordeste en Plaza de Castilla hacia la Calle de Mateo Inurria, gire a la derecha, y continúe por la Calle de los Caídos de la División Azul. Gire a la izquierda en la Avenida de Pío XII, tome el ramal e incorpórese a la Calle 30.

• Continúe por la A-1 (indicaciones para A-1 / Alcobendas / Burgos).

• Salga por la salida 26, recorra 600 metros por la vía de servicio, y llegará a la entrada de Farmasierra al pasar la Gasolinera GALP.

• Diríjase hacia el oeste por la M-111 durante 2,3 km (unos 3 minutos) hasta la rotonda, y tome la segunda salida por el ramal M-13 en dirección A-1/M-12. Manténgase a la izquierda en la bifurcación para continuar en dirección Autovía M-13/M-13 e incorporarse a la Autovía M-13/M-13.

• Tome la salida 0A hacia la Autopista Eje-Aeropuerto y manténgase a la izquierda en la bifurcación. Siga las indicaciones hacia la R-2/Zaragoza/M-50/Burgos/A1, e incorpórese a la Autopista Eje-Aeropuerto. En la siguiente rotonda, tome la primera salida por el ramal A-1/E-5 en dirección Burgos, e incorpórese a la E-5/A-1.

• Salga por la salida 26, recorra 600 metros por la vía de servicio, y llegará a la entrada de Farmasierra al pasar la Gasolinera GALP.